Physician profile
Andrew Weinstein
NPI 1508829862
$2,543.76
in general payments reported to CMS, 2019-2025
18 companies · $482 in 2025
The $482 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,116 · 2020: $279 · 2021: $182 · 2022: $239 · 2023: $246 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $460.41 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $344.16 | 2019-2022 | |
| Abbott Laboratories | $253.78 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $188.50 | 2019-2020 | |
| Leo Pharma INC. | $186.31 | 2022-2025 | Adbry |
| Pfizer INC. | $184.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $175.25 | 2019-2021 | |
| Recor Medical INC | $161.98 | 2025 | Paradise Ultrasound Renal Denervation System |
| Heartflow, INC. | $144.27 | 2022 | |
| Novo Nordisk INC | $121.32 | 2019 | |
| Boston Scientific Corporation | $70.66 | 2019 | |
| Amgen INC. | $64.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $49.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $44.11 | 2019-2022 | |
| Galderma Laboratories, L.P. | $41.55 | 2020-2023 | Epsolay, Aklief |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $27.03 | 2019 | |
| Gilead Sciences, INC. | $14.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.